In this study we show that the small-molecule BET inhibitor JQ1 exerts growth inhibitory effects on a representative panel of TNBC and ER+ breast cancer cell lines and that this is associated with global changes in gene expression. This evidence concerns the gene ESR1 and breast carcinoma.